Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Stock Forecast

VRCA's stock price has decreased by -92.69% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 5 analysts that cover Verrica Pharmaceuticals stock have a consensus rating of "Hold" and an average price target of $6, which forecasts a 925.99% increase in the stock price over the next year. The lowest target is $2 and the highest is $10.

Price Target: $6 (+925.99%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$2.00	$6.00	$10	$10
Change	+242.00%	+925.99%	+1610.0%	+1610.0%

* Price targets were last updated on Nov 5, 2024.

Analyst Ratings

The average analyst rating for Verrica Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	4	4	4	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	May 14, 2025
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Apr 9, 2025
Oren Livnat HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Apr 8, 2025
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 12, 2025
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Dec 20, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

20.57M

Increased by 171.87%

from 7.57M

Revenue Next Year

35.25M

Increased by 71.38%

from 20.57M

EPS This Year

-0.27

from -1.48

EPS Next Year

-0.25

from -0.27

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	12.00M	9.03M	5.12M	7.57M	20.57M	35.25M	57.00M
Revenue Growth	-	-	-24.73%	-43.27%	47.66%	171.87%	71.38%	61.70%
EPS	-1.71	-1.30	-0.72	-1.48	-1.48	-0.27	-0.25	-0.09
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	6	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	26.7M	52.5M	126.0M
Avg	20.6M	35.3M	57.0M
Low	14.7M	23.2M	20.0M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	252.5%	155.2%	257.4%
Avg	171.9%	71.4%	61.7%
Low	94.3%	12.8%	-43.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.27	-0.25	-0.02
Avg	-0.27	-0.25	-0.09
Low	-0.27	-0.24	-0.16

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.